Michael J. Fox Foundation for Parkinson’s Research (MJFF): LRRK2 Challenge

The LRRK2 ChallengeĀ seeks to support work that can significantly contribute to a better understanding of the gene/protein leucine-rich repeat kinase 2 (LRRK2), its relevance to Parkinsonā€™s disease (PD) and effective ways to translate LRRK2 research into therapies for patients.

Funding & Duration

Applicants may submit a proposal focused on a relevant area of LRRK2 for consideration of a one-year, US $125,000 award. Successful applicants will be granted membership in the MJFF LRRK2 Consortium, where they can share information, data and resources with other awardees of this and other MJFF LRRK2-related efforts.


Applications may be submitted by:

  • U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held,
  • U.S. and non-U.S. entities, public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.

Post-doctoral fellows are NOT eligible to apply as Principal Investigators to this program.

Further Information

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Ongoing Opportunities. Bookmark the permalink.

Comments are closed.